Pharmaceutical product research and development can take up to 15 years. Pharmaceutical companies prefer to outsource preclinical and other drug development phases to CROs in order to save money on R&D and shorten the time it takes to market a product. Furthermore, a high failure rate of clinical trials is expected to fuel the demand for CROs by pharmaceutical and biopharmaceutical vendors looking to outsource their R&D.
Read More…